Event begins in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Kerry Hotel Pudong
April 23–24, 2025 | Shanghai, ChinaApril 29–30, 2025 | Virtual Tae Erk KimCEO at Crosspoint TherapeuticsPresenter
Profile
Description or SummaryDeveloping next gen ADC and immune agonistic anti cancer antibody therapies based on proprietary Fc silent platform technology. We have 1 lead stage immuno-oncology pipeline targeting CD47 and CD40 and 1 lead tage ADC pipeline targeting EGFR
Agenda Sessions
Oncology: Crosspoint Therapeutics
, 10:45View Session